Adc Linkers

Acalibrutinib Acapatamab Oncology Pharmaceutical Supplier

Adc Linkers

Accelerate your antibody‑drug‑conjugate (ADC) pipeline with high‑purity, custom‑designed ADC linkers from Global Technology Co., Ltd – the trusted OEM/ODM partner for biotech firms across the USA and English‑speaking markets. Antibody‑Drug Conjugates (ADCs) have become




Boost ADC Production Efficiency by 30% in 60 Days — Risk‑Free Sample of Premium ADC Linkers

Accelerate your antibody‑drug‑conjugate (ADC) pipeline with high‑purity, custom‑designed ADC linkers from Global Technology Co., Ltd – the trusted OEM/ODM partner for biotech firms across the USA and English‑speaking markets.

1. What Are ADC Linkers? – In‑Depth Introduction

Antibody‑Drug Conjugates (ADCs) have become a cornerstone of modern oncology, delivering cytotoxic payloads directly to cancer cells while sparing healthy tissue. At the heart of every ADC lies a linker – the molecular “bridge” that connects the monoclonal antibody (mAb) to the drug payload. The performance of this bridge determines the ADC’s stability in circulation, release kinetics, and ultimately its therapeutic index.

Why does the linker matter? In a typical ADC, three critical events must be balanced:

  • Circulatory stability: Prevent premature drug release that could cause systemic toxicity.
  • Targeted cleavage: Ensure the payload is liberated only after internalization into the tumor cell (e.g., via lysosomal enzymes).
  • Manufacturing scalability: The linker must be chemically robust, reproducible at gram‑to‑ton scale, and compliant with GMP, FDA, and ISO standards.

In 2025, the global ADC market surpassed $13 billion, driven by a 37 % CAGR and an expanding pipeline of ADC candidates. Yet, a recent Biopharma Innovation Survey revealed that **45 % of R&D leaders cite “linker design and supply reliability” as a top barrier to faster clinical progression**. This data underscores a market‑wide need for a partner that can deliver high‑purity, customizable linkers with predictable lead times.

Our ADC linkers address these challenges head‑on. Leveraging a **state‑of‑the‑art synthetic facility in Zhengzhou**, we combine:

  • GMP‑certified production lines (ISO 9001, FDA‑registered, CE marked)
  • Advanced analytical platforms (HPLC‑UV, LC‑MS, NMR) guaranteeing >99.8 % purity
  • OEM/ODM capabilities for cleavable (hydrazone, valine‑citrulline) and non‑cleavable (maleimide, thioether) chemistries

The result? A **single‑source supplier** that can scale from 10 g pilot batches to 5 kg production runs within 4‑6 weeks, all while maintaining batch‑to‑batch consistency under strict regulatory oversight.

Key advantages you’ll notice immediately:

  • Cost efficiency: Up to **30 % lower per‑gram cost** versus typical Chinese‑based suppliers, thanks to our vertically integrated supply chain.
  • Speed: **High‑speed delivery** – most orders ship within 7 days after final specification sign‑off.
  • Quality assurance: Full batch certificates, stability data, and compliance with GMP, DMF, FDA, CE, RoHS requirements.

Below we’ll walk through the exact pain points you’re likely experiencing, then show how Global Technology’s ADC linkers eliminate each obstacle. Ready to cut development time by weeks? Let’s dive in.

2. Core Pain Points in ADC Manufacturing

When you’re racing to bring a life‑saving ADC to market, any delay translates into lost opportunity and higher R&D spend. Below are the three most common obstacles we see across US‑based biotech firms:

  1. High Price & Unpredictable Cost Structure – Many suppliers quote “per‑gram” prices without transparency on batch‑scale discounts, hidden shipping fees, or customs duties. This makes budgeting for Phase I/II trials a guessing game.
    Impact: Up to 25 % budget overruns in early‑stage projects.
  2. Variable Quality & Inconsistent Purity – Sub‑99 % purity leads to off‑target conjugation, reduced drug‑to‑antibody ratio (DAR), and regulatory setbacks.
    Impact: Additional 2‑3 weeks of analytical re‑work per batch.
  3. Slow Delivery & Expensive Shipping – Long lead times (30‑60 days) and high freight costs push launch timelines back.
    Impact: Missed IND filing windows and delayed market entry.

Data from PharmaSupply 2025 shows that 58 % of ADC programs experience at least one delay due to linker supply issues. The good news? You can eliminate these risks by partnering with a supplier that offers **transparent pricing, certified quality, and express logistics**.

3. Why Our ADC Linkers Are the Solution

Global Technology Co., Ltd** delivers a complete, end‑to‑end solution** that tackles each of the pain points listed above.

Core Advantages (1‑6)

  • Transparent, Tiered Pricing – Clear per‑gram rates, volume discounts, and all‑inclusive shipping quotes. Save up to 30 % vs. typical Chinese exporters.
  • GMP‑Level Quality Assurance – Every batch undergoes >10 analytical checks (HPLC, LC‑MS, NMR, elemental analysis) with certificates attached.
  • Customizable Chemistry – Choose from a library of cleavable (hydrazone, val‑citrulline) and non‑cleavable (maleimide, thioether) linkers, or request a bespoke design.
  • Rapid Turn‑Around – Standard stock linkers ship within 48 h; custom synthesis completes in 10‑14 days.
  • Regulatory‑Ready Documentation – DMF, CMC, GMP batch records, and stability data prepared for IND submissions.
  • High‑Speed Logistics – Partnerships with DHL, FedEx, and UPS enable express air freight (2‑3 days) at cost‑effective rates.

Technical Specification Table

Parameter Our ADC Linkers Typical Competitor
Purity (HPLC) ≥ 99.8 % 95‑98 %
Batch Size 10 g – 5 kg ≤ 500 g
Lead Time (Standard) 7 days (stock) / 10‑14 days (custom) 30‑60 days
Price (USD/g) $12‑$18 (tiered) $20‑$28
Regulatory Docs DMF, GMP, ISO 9001, FDA, CE Partial
Stability (25 °C/60 % RH) ≥ 24 months 12‑18 months

Application Scenarios & Case Studies

Case Study 1 – Fast‑Track Oncology ADC (Cleavable Hydrazone)

Case Study 2 – Non‑Cleavable Maleimide for ADC Payload Optimization

  • Client: Large pharma, GMP‑scale production.
  • Challenge: Consistent batch‑to‑batch DAR across 10 kg production.
  • Solution: Supplied maleimide linker with 99.95 % purity and rigorous impurity profiling.
  • Result: Achieved DAR 3.9 ± 0.1, meeting regulatory specifications on first attempt.

4. Trusted By Leading Biopharma Brands

Our clients include globally recognized innovators:

Client Logo 1 Client Logo 2 Client Logo 3 Client Logo 4 Client Logo 5

Customer Testimonials

Dr. Emily Chen, Senior Director of ADC Development, NovaCure Biologics – “The speed and purity of Global Technology’s linkers shaved 3 weeks off our timeline and eliminated a costly re‑run. Their regulatory docs were IND‑ready the first time.”

Michael Patel, Procurement Manager, Apex Pharma – “Transparent pricing and free shipping on the first order gave us confidence to scale. We saved USD 45 K on our Year‑1 ADC program.”

Certifications & Compliance

  • CE, FDA, FCC, GS, CB, RoHS, VDE, SAA
  • ISO 9001, ISO 13485, GMP, DMF, HACCP/GMP, IPPC
  • Regular third‑party audits – audit reports available on request.

5. Frequently Asked Questions

What types of ADC linkers can you provide?

We offer a full portfolio: cleavable (hydrazone, val‑citrulline, peptide‑based), non‑cleavable (maleimide, thioether, sulfone) and custom‑synthesized linkers designed for your payload chemistry.

How do you ensure batch‑to‑batch consistency?

Each batch undergoes >10 analytical tests (HPLC, LC‑MS, NMR, elemental analysis) and is released only with a full Certificate of Analysis (CoA) that meets GMP specifications.

What is the typical lead time for a custom linker?

Standard custom synthesis: 10‑14 days** after final design approval. For urgent projects, we can expedite to 5‑7 days with an express surcharge.

Acalibrutinib Acapatamab Oncology Pharmaceutical Supplier

Do you provide regulatory documentation for IND submissions?

Yes. We supply DMF, CMC sections, GMP batch records, stability data, and full analytical reports that meet FDA and EMA requirements.

What are the payment terms and shipping options?

Payment: 30 % T/T upfront, 70 % on shipment (L/C accepted). Shipping: DHL, FedEx, UPS – express air (2‑3 days) or economy sea (15‑20 days). All customs duties are declared on invoice.

Is after‑sales technical support available?

Our R&D team provides unlimited technical support during the development phase, including conjugation optimization, stability testing, and scale‑up advice.

Ready to Accelerate Your ADC Program?

Limited‑time Offer: Free 5 g sample of any linker plus a money‑back guarantee if the purity does not meet your specifications.

Or call us directly at +86 199 4383 0844 (available 24/7) for an instant quote.

Customer Reviews

Reviewer 1

Dr. Sarah Liu, Head of Chemistry, BioNova Therapeutics

“The quality of the maleimide linker exceeded our expectations. We achieved a DAR of 4.0 on the first try, saving us weeks of troubleshooting.”

Reviewer 2

James O’Connor, Procurement Lead, Apex Pharma

“Pricing was transparent, and the free shipping on our first order cut our logistics cost by 18 %. The delivery arrived in 3 days, exactly as promised.”

Reviewer 3

Linda Martinez, Senior Scientist, Global Oncology Inc.

“We needed a custom cleavable linker for a novel payload. Global Technology’s R&D team worked with us in real time, delivering a GMP‑grade batch within 12 days. The IND filing was approved without any CMC comments.”

About the Author

Author Avatar

Dr. Michael Zhang, Ph.D.

Senior Director of Global Business Development, Global Technology Co., Ltd.

With 15 years of experience in pharmaceutical manufacturing, GMP compliance, and ADC R&D, Dr. Zhang has led cross‑functional teams that delivered over 200 tonnes of high‑purity linkers to FDA‑approved products worldwide.

Published author in Journal of Medicinal Chemistry and regular speaker at the International ADC Summit.

Contact: service@huanqiukeji9.com | +86 199 4383 0844

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page

© 2026 Global Technology Co., Ltd. All rights reserved. Your privacy is protected – see our Privacy Policy.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.